RAPGEF5 and intrahepatic cholangiocarcinoma: In our study, we analyzed 19 pairs of clinical samples of tumors and adjacent tissues and found that Circ-RAPGEF5 is highly expressed in ICC tumor tissues, suggesting a potential oncogenic role of Circ-RAPGEF5.